British Pro-Abortion Organization
Pushes Changes to
Chemical Abortion Technique that Would Increase Risks to Women
By Dave Andrusko
A major component of the
International Abortion Industry's campaign to expand the number
of abortions is the use of chemical abortifacients, typically
the two-drug abortion RU-486 technique. In so doing, it has
ignored the FDA's recommendation that mifepristone and
misoprostol be used no later than seven weeks into pregnancy.
RU-486 is now routinely used through nine weeks, increasing
health risks.
The key player in Great Britain's
Abortion Establishment, The British Pregnancy Advisory Service (BPAS),
is taking the Department of Health to court for its refusal to
buckle to BPAS's latest demand which also would increase the
danger to women. BPAS wants the 1967 Abortion Act changed--or
reinterpreted--to mean that women can take the second set of
pills at home, rather than in a hospital or a clinic.
The BPAS argues that the language
of the 1967 law that requires "treatment" to be given in a
hospital or a clinic should be interpreted to cover the
prescription of the pills, but not their administration.
A spokeswoman for the Department
of Health told the BBC, "It is the government's view that the
words 'any treatment for the termination of pregnancy' under
section 1(3) of the Abortion Act 1967 cover both the
prescription and the administration of the drugs used in
abortion. In the government's view, this means that both tablets
used for medical abortion must be administered on premises which
have been approved under the Abortion Act."
NRLC Director of Education Dr.
Randall K. O'Bannon has explained in detail the many shortcuts
the abortion industry has taken, elevating the risks to women (http://www.nrlc.org/News_and_Views/Oct10/nv101410part2.html).
Among the most dangerous are:
* Changing the respective dosages
of mifepristone and misoprostol.
* Promoted at-home, vaginal
self-administration of RU486.
"Generally, this seems to be one
more example of the attempt to try to decrease the involvement
of the clinic and its staff in the abortion," said Dr..
O'Bannon. "If BPAS succeeds, it not only spares them the
agony--and the trauma--of waiting on and watching the woman
abort, but it also reduces expenses and dumps problems on the
emergency rooms."
But O'Bannon added that what it
definitely does not do is increase safety.
"It makes the doctors and staff
less involved, more remote, less able to monitor the woman
precisely when she is bleeding the most and undergoing what is
probably the riskiest part of her abortion," he said.
Please send your comments on
Today's News & Views and National Right to Life News Today to
daveandrusko@gmail.com.
If you like, join those who are following me on Twitter at
http://twitter.com/daveha.
|